v3.26.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (3,681,180) $ (1,605,511)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 24,610 33,304
Stock based compensation 499,740 259,300
Amortization of license fees 13,125 11,250
Issuance of common stock for services 181,500
Loss on issuance of convertible note 322,359
Amortization of right-of-use assets, net of liabilities (6,238) (3,676)
Amortization of debt discount 515,583
Change in fair value of derivative liability 148,766
Changes in operating assets and liabilities:    
Accounts receivable (91,532) (38,979)
Inventory 5,181 (14,496)
Prepaid expenses and other assets 2,014 53,770
Accounts payable 158,265 184,333
Accrued liabilities (29,883) 192,468
Deferred revenue 43,270 (94,161)
Net cash used in operating activities (1,894,420) (1,022,398)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of intangible assets, including patents (5,354)
License agreement (7,500)
Net cash used in investing activities (12,854)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of convertible notes payable 250,000 70,000
Proceeds from issuance of Series D preferred stock 192,338
Proceeds from issuance of series E convertible preferred stock 6,000,000
Offering costs (822,573)
Net cash provided by financing activities 5,427,427 262,338
Increase (decrease) in cash and cash equivalents 3,520,153 (760,060)
Cash and cash equivalents, beginning of period 1,025,987 1,784,009
Cash and cash equivalents, end of period 4,546,140 1,023,949
Supplemental disclosures of cash flow information:    
Cash paid for interest
Cash paid for income taxes
Non-cash disclosures of cash flow information:    
Conversion of preferred stock to common stock 289,193
Deferred offering costs – issuance of common stock and warrants as offering costs 3,654,057
Accrued dividends on series E convertible preferred stock 121,662
Deemed dividend on warrant modifications 1,124,676
Issuance of preferred stock for dividends on series E convertible preferred stock 54,192
Derivative liabilities recognized as debt discounts 541,199
Derivative liabilities reclassified to equity 1,361,306
Conversion of convertible notes payable and accrued interest to common stock 834,812
Conversion of convertible notes payable and accrued interest to Series E Preferred $ 583,197